Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

ZZM-1220

ZZM-1220 is a histone lysine methyltransferase G9a/GLP covalent inhibitor with IC50s of of 458 nM and 924 nM, respectively. ZZM-1220 inhibits H3K9me2 in cells and significantly induces apoptosis of triple-negative breast cancer (TNBC) cells and blocks the cell cycle in the G2/M phase[1].

Product Specifications

UNSPSC

12352005

Target

Apoptosis; Histone Methyltransferase

Type

Reference compound

Related Pathways

Apoptosis; Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/zzm-1220.html

Purity

98.74

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C=CC(NC1=CC(C2=NC3=CC(OC)=C(C=C3C(NC4CCN(CC4)C)=N2)OC)=CC=C1)=O

Molecular Formula

C25H29N5O3

Molecular Weight

447.53

References & Citations

[1]Qiangsheng Zhang, et al. Discovery of novel G9a/GLP covalent inhibitors for the treatment of triple-negative breast cancer. Eur J Med Chem. 2023 Sep 28:261:115841.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

EHMT1/GLP/KMT1D; EHMT2/G9a/KMT1C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

PDE10A Rabbit Polyclonal Antibody
E28PT3627 100 µL

PDE10A Rabbit Polyclonal Antibody

Ask
View Details
Twinfilin 1 Antibody / TWF1 / PTK9
RQ8157 100 µg

Twinfilin 1 Antibody / TWF1 / PTK9

Ask
View Details
SB271046
M17426-01 1 g

SB271046

Ask
View Details
SB271046
M17426-02 200 mg

SB271046

Ask
View Details
SB271046
M17426-03 500 mg

SB271046

Ask
View Details
SB271046
M17426-04 5 mg

SB271046

Ask
View Details